UBS Group
BTCY

UBS Group’s Biotricity, Inc. Common Stock BTCY Stock Holding History

UBS Group’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,225
Closed -$8.3K – 10425
2024
Q2 		$8.3K Buy
+9,225
New +$10.6K ﹤0.01% 7806
2023
Q4 		– Sell
-1,416
Closed -$3.03K – 10176
2023
Q3 		$3.03K Buy
1,416
+734
+108% +$1.77K ﹤0.01% 7616
2023
Q2 		$2.61K Buy
+682
New +$2.54K ﹤0.01% 7725
2023
Q1 		– Sell
-2,623
Closed -$7.08K – 10755
2022
Q4 		$7.08K Buy
2,623
+2,456
+1,471% +$13.6K ﹤0.01% 8942
2022
Q3 		$1K Sell
167
-849
-84% -$5.96K ﹤0.01% 10105
2022
Q2 		$11K Sell
1,016
-462
-31% -$4.03K ﹤0.01% 7873
2022
Q1 		$20K Buy
1,478
+506
+52% +$8.78K ﹤0.01% 7467
2021
Q4 		$23K Buy
+972
New +$22.9K ﹤0.01% 7695

Other funds holding BTCY

SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PWA
Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

UBS Group's BTCY Position: Q3 2024 in Review

UBS Group sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 9,225 shares — an estimated $8.3K sold.

UBS Group first reported a position in BTCY in Q4 2021 and held it in 8 quarters. The position peaked at $23K in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

  • UBS Group reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 9,225 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $8.3K.
  • UBS Group first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • UBS Group's Biotricity, Inc. Common Stock position peaked at $23K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.